Nasdaq
$9.17▲ 0.05%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.55BShares out 1.700M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
8- 10.14After-hours26.10.15 08:164Ownership#●●●
Absci Corp
Absci Corp insider Sean McClain filed a Form 4 on October 14, 2026, to report changes in beneficial ownership of securities as of October 12, 2026. This filing serves as a standard disclosure of insider equity transactions.…more
$9.17+0.05%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.14After-hours26.10.15 08:154Ownership
Absci Corp
Absci Corp insider Todd Bedrick reported a change in beneficial ownership of securities effective October 12, 2026. This filing is a standard Form 4 disclosure regarding insider equity transactions.…more
$9.17+0.05%vs prev closeView filingShare - 10.14After-hours26.10.15 08:144Ownership
Absci Corp
Insider Zachariah Jonasson of Absci Corp reported a change in beneficial ownership of securities effective October 12, 2026. This filing serves as a standard Form 4 disclosure regarding executive equity transactions.…more
$9.17+0.05%vs prev closeView filingShare
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.24Pre-market26.09.24 21:00#●●●#●●●
Absci Announces Phase 2 Clinical Trial Plans for AI-Designed Endometriosis Drug…more
Absci has released preliminary details for its upcoming Phase 2 clinical trial of ABS-201, an AI-designed antibody for treating endometriosis. The company anticipates initiating the trial in mid-2027, though it remains in the early stages of development.…more
$9.17+0.05%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.11Regular26.09.12 00:58
●●●●●●●● ●●●●● ●●●●●●
Eli Lilly is leveraging profits from its weight-loss medications to fund research and expansion into the women's health sector, including conditions like endometriosis. The company is focusing on long-term growth through strategic investments and talent acquisition rather than immediate large-scale mergers.…more
$9.17+0.05%vs prev closeShareBenzinga - 9.1Pre-market26.09.01 21:00
●●●●●●●● ●●●●● ●●●●●●
Absci announced its participation in the upcoming H.C. Wainwright and Morgan Stanley investor conferences in September. These sessions are standard corporate presentations and do not contain new material business developments or financial results.…more
$9.17+0.05%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report